Effect of soy protein varying in isoflavone content on serum lipids in healthy young men.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Clinical Nutrition

• Publication date

  2006-02-01

• Fields of study

  Agricultural and Food Sciences, Medicine, Chemistry

• Identifiers
  DOI 10.1093/AJCN/83.2.244PMID 16469981
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soy protein isolates of varying isoflavone content exert minor effects on serum reproductive hormones in healthy young men.

  2005cited by this paper
• Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults.

  2005cited by this paper
• Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women.

  2004cited by this paper
• Soy protein reduces triglyceride levels and triglyceride fatty acid fractional synthesis rate in hypercholesterolemic subjects.

  2004cited by this paper
• Beneficial Effects of Soybean Isoflavone Supplementation on Bone Metabolism and Serum Lipids in Postmenopausal Japanese Women: A Four-Week Study

  2002cited by this paper
• Soy, soy phytoestrogens and cardiovascular disease.

  2002cited by this paper
• The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.

  2002cited by this paper
• Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women.

  2002cited by this paper
• C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study.

  2002cited by this paper
• Alcohol-Extracted, but Not Intact, Dietary Soy Protein Lowers Lipoprotein(a) Markedly

  2002cited by this paper
• A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects.

  2002cited by this paper
• Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women.

  2002cited by this paper
• Accuracy of lipoprotein lipids and apoproteins in predicting coronary heart disease in diabetic American Indians. The Strong Heart Study.

  2002cited by this paper
• Soy in hypercholesterolaemia: a double-blind, placebo-controlled trial

  2002cited by this paper
• Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor beta(1) concentrations and hemostatic risk factors for coronary heart disease in healthy subjects.

  2002cited by this paper
• Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women.

  2001cited by this paper
• Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women.

  2001cited by this paper
• Ethanol-extracted soy protein isolate does not modulate serum cholesterol in golden Syrian hamsters: a model of postmenopausal hypercholesterolemia.

  2001cited by this paper
• Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women.

  2001influential reference
• Soy protein isoflavones, lipids and arterial disease

  2001cited by this paper
• Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women.

  2001cited by this paper
• Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study(1-4).

  2001cited by this paper
• AHA Science Advisory: Soy protein and cardiovascular disease: A statement for healthcare professionals from the Nutrition Committee of the AHA.

  2000cited by this paper
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000cited by this paper
• Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men.

  2000influential reference
• Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population.

  2000cited by this paper
• Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women.

  2000cited by this paper
• Interindividual Variation in Metabolism of Soy Isoflavones and Lignans: Influence of Habitual Diet on Equol Production by the Gut Microflora

  2000cited by this paper
• Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.

  2000cited by this paper
• Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women.

  2000cited by this paper
• A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins.

  1999influential reference
• Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule.

  1999cited by this paper
• Ethanol-extracted soy protein isolate results in elevation of serum cholesterol in exogenously hypercholesterolemic rats

  1999cited by this paper
• Hormone replacement therapy and increased plasma concentration of C-reactive protein.

  1999cited by this paper
• Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study.

  1999cited by this paper
• Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein.

  1999cited by this paper
• Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans.

  1998cited by this paper
• Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice.

  1998cited by this paper
• Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women.

  1998cited by this paper
• Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men.

  1998influential reference
• Soybean Protein Products as Regulators of Liver Low-Density Lipoprotein Receptors. I. Identification of Active β-Conglycinin Subunits

  1998cited by this paper
• Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys.

  1997cited by this paper
• An extract of soy flour influences serum cholesterol and thyroid hormones in rats and hamsters.

  1996cited by this paper
• Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys.

  1996cited by this paper
• A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men.

  1996cited by this paper
• Meta-analysis of the effects of soy protein intake on serum lipids.

  1995cited by this paper
• Serum cholesterol in young men and subsequent cardiovascular disease.

  1993influential reference
• Low density lipoprotein receptor activity is modulated by soybean globulins in cell culture.

  1992cited by this paper
• International trends in coronary heart disease mortality, morbidity, and risk factors.

  1990cited by this paper
• Measurement of proteins with the Behring Nephelometer. A multicentre evaluation.

  1989cited by this paper
• Dietary protein effects on cholesterol and lipoprotein concentrations: a review.

  1986cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Portfolio diet and LDL-C in a young, multiethnic cohort: cross-sectional analyses with cumulative exposure modeling

  2025cites this paper
• The Effect of Increased Plant Protein Intake on the Lipid Profile of Chronic Kidney Disease Patients: A Meta-Analysis of Controlled Clinical Trials

  2025cites this paper
• Energy Conservation Program : Test Procedure for Distribution Transformers

  2023cites this paper
• Animal versus plant-based protein and risk of cardiovascular disease and type 2 diabetes: a systematic review of randomized controlled trials and prospective cohort studies

  2023cites this paper
• Findings from meta-analysis of soy supplementation and inflammatory biomarkers should be interpreted with caution.

  2022cites this paper
• Salinity-induced Changes In Growth, Physiology And Yield Of Soybean Genotypes

  2022cites this paper
• Soy protein supplementation in men following radical prostatectomy: a 2-year randomized, placebo-controlled clinical trial.

  2021cites this paper
• Atualização da Diretriz Brasileira de Hipercolesterolemia Familiar – 2021

  2021cites this paper
• Fatty Acids and Osteoarthritis: The MOST Study.

  2021cites this paper
• Update of the Brazilian Guideline for Familial Hypercholesterolemia – 2021

  2021cites this paper
• A Review of Medicinal Plants in Cardiovascular Disorders: Benefits and Risks.

  2020cites this paper
• Regulation of apolipoprotein B by natural products and nutraceuticals: a comprehensive review.

  2020cites this paper
• The effects of soy supplementation on inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials.

  2020cites this paper
• Soybean (Glycine max)

  2020cites this paper
• Effect of S-equol and Soy Isoflavones on Heart and Brain

  2019cites this paper
• A systematic review and meta-analysis of the effects of soy on serum hs-CRP.

  2019cites this paper
• A Meta-Analysis of 46 Studies Identified by the FDA Demonstrates that Soy Protein Decreases Circulating LDL and Total Cholesterol Concentrations in Adults.

  2019cites this paper
• Cumulative Meta‐Analysis of the Soy Effect Over Time

  2019cites this paper
• Biomarkers of the metabolic syndrome: influence of selected foodstuffs, containing bioactive components

  2017cites this paper
• Hyperlipidemia and associated risk factors: synthetic drugs or medicinal plants? An important question

  2017cites this paper
• Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview

  2017cites this paper
• Theobromine: effects on postprandial metabolism, vascular function and intestinal gene expression in humans

  2017cites this paper
• Effect of Plant Protein on Blood Lipids: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

  2017influential citation
• A Systematic Review of the Effects of Plant Compared with Animal Protein Sources on Features of Metabolic Syndrome.

  2017cites this paper
• Nutritional management of hyperapoB

  2016cites this paper
• Effect of Soy Bean Consumption on Quality of Life of Middle Aged Women

  2016cites this paper
• Impact of Flaxseed Consumption on Dyslipidemia

  2016cites this paper
• The impact of equol-producing status in modifying the effect of soya isoflavones on risk factors for CHD: a systematic review of randomised controlled trials

  2016influential citation
• A Systematic Review of the Efficacy of Bioactive Compounds in Cardiovascular Disease: Phenolic Compounds

  2015influential citation
• Soy and Soy-Based Products

  2015cites this paper
• Whole Grains and Metabolic Syndrome

  2015cites this paper
• Proposition de Santé Canada d'accepter une allégation santé au sujet des produits à base de soya et de la diminution du cholestérol

  2014cites this paper
• Justification for soy protein to still have a category ‘A’ coronary heart disease risk reduction health claim

  2014cites this paper
• Isoflavone and Protein Constituents of Lactic Acid-Fermented Soy Milk Combine to Prevent Dyslipidemia in Rats Fed a High Cholesterol Diet

  2014cites this paper
• Health Canada’s Proposal to Accept a Health Claim about Soy Products and Cholesterol Lowering

  2014cites this paper
• Changes of bone metabolism based on the different interventions with exercise type or additional intake material in ovariectomized rats

  2014cites this paper
• Soybean (Glycine max L): A Synonym for Nutrition, Health and Longevity

  2014cites this paper
• Potential of Soy Phytochemicals in Cardiomyocyte Regeneration and Risk Reduction of Coronary Heart Disease

  2013cites this paper
• Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications

  2013cites this paper
• Amelioration of selected cardiac risk factors through supplementation of diet with flaxseed and soya bean

  2013cites this paper
• Respon Stres Oksidatif dan Pemberian Isoflavon terhadap Aktivitas Enzim Superoksida Dismutase dan Peroksidasi Lipid pada Hati Tikus

  2013cites this paper
• Anti-Obesity and Antihyperglycemic Effects of Crataegus aronia Extracts: In Vitro and in Vivo Evaluations

  2013influential citation
• I BRAZILIAN GUIDELINE FOR FAMILIAL HYPERCHOLESTEROLEMIA (FH) I BRAZILIAN GUIDELINE FOR FAMILIAL HYPERCHOLESTEROLEMIA (FH)

  2013cites this paper
• Effects of Black Soybean on Atherogenic Prevention in Hypercholesterolemic Rabbits and on Adhesion Molecular Expression in Cultured HAECs

  2013cites this paper
• Plant foods and inflammatory processes

  2013cites this paper
• Evidence-based nutritional recommendations for the prevention and treatment of overweight and obesity in adults (FESNAD-SEEDO consensus document). The role of diet in obesity treatment (III/III).

  2012cites this paper
• EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to isolated soy protein and reduction of blood LDL-cholesterol concentrations pursuant to Article 14 of Regulation (EC) No 1924/2006

  2012influential citation
• Evidence-based nutritional recommendations for the prevention and treatment of overweight and obesity in adults (FESNAD-SEEDO consensus document). The role of diet in obesity prevention (II/III).

  2012cites this paper
• Effects of soy on metabolic biomarkers of cardiovascular disease in elderly women with metabolic syndrome.

  2012cites this paper
• Effects of Soybean Seed on Glucose Levels , Lipid Profiles and Histological Structures of the Liver in Alloxan-Induced Diabetic Albino Rats

  2012cites this paper
• Elucidation of role of antioxidant molecules and enzymes in reduction / elimination of off-flavour in soybean ( Glycine max ) Ms

  2012cites this paper
• Scientific Opinion on the substantiation of a health claim related to isolated soy protein and reduction of blood LDL-cholesterol concentrations pursuant to Article 14 of Regulation (EC) No 1924/2006: Isolated soy protein and reduction of blood LDL-cholesterol concentrations

  2012cites this paper
• I Diretriz Brasileira de Hipercolesterolemia Familiar (HF)

  2012cites this paper
• Phytochemicals from plants to combat cardiovascular disease.

  2012cites this paper
• Soy intake and metabolic health: beyond isoflavones.

  2012cites this paper
• evidencia para la prevención y el tratamiento del sobrepeso y la obesidad en adultos ( consenso FESNAD-SEEDO ) . La dieta en la prevención de la obesidad ( II / III )

  2012cites this paper
• Soy Protein Effects on Serum Lipoproteins: A Quality Assessment and Meta-Analysis of Randomized, Controlled Studies

  2011cites this paper
• Soy β-Conglycinin (7S Globulin) Reduces Plasma and Liver Cholesterol in Rats Fed Hypercholesterolemic Diet

  2011cites this paper
• Polyamines - The Principal Candidate Substance of Soybean-Induced Health

  2011cites this paper
• Dietary factors and low-grade inflammation in relation to overweight and obesity

  2011cites this paper
• Soy and health: The latest evidence

  2011cites this paper
• 미국 메디케어 의약품급여제도(Part D)의 평가와 시사점

  2011cites this paper
• Scientific Opinion on the substantiation of a health claim related to isolated soy protein and reduction of blood LDL-cholesterol concentrations pursuant to article 14 of regulation (EC) no 1924/2006.

  2010cites this paper
• Functional food product development.

  2010cites this paper
• A comparative assessment of total phenolic content, ferric reducing-anti-oxidative power, free radical-scavenging activity, vitamin C and isoflavones content in soybean with varying seed coat colour

  2010cites this paper
• The Use of Functional Plant Ingredients for the Development of Efficacious Functional Foods

  2010cites this paper
• Soy Sauce Fermentation

  2010cites this paper
• Gamma irradiation induced enhancement in isoflavones, total phenol, anthocyanin and antioxidant properties of varying seed coat colored soybean.

  2010cites this paper
• Mechanisms of anti-atherosclerotic functions of soy-based diets.

  2010cites this paper
• Effects of soy protein on lipoprotein lipids and fecal bile acid excretion in men and women with moderate hypercholesterolemia.

  2010cites this paper
• Postprandial Lipemia Detects the Effect of Soy Protein on Cardiovascular Disease Risk Compared with the Fasting Lipid Profile

  2010cites this paper
• The metabolic syndrome: definition, global impact, and pathophysiology.

  2009cites this paper
• Effects of isoflavone-supplemented soy yogurt on lipid parameters and atherosclerosis development in hypercholesterolemic rabbits: a randomized double-blind study

  2009cites this paper
• Use of Soy Bean Products as Cheap Sources of Protein in Child-Nutrition in Akpuoga Nike Community, in Enugu State South East, Nigeria

  2009cites this paper
• Lipids in Health and Disease

  2009cites this paper
• Soy constituents: modes of action in low-density lipoprotein management.

  2009cites this paper
• Organic and Genetically Modified Soybean Diets: Consequences in Growth and in Hematological Indicators of Aged Rats

  2009cites this paper
• Biotransformation of Free Isoflavones by Bacillus Species Isolated from Traditional Cheonggukjang

  2009cites this paper
• Märehtijöiden rehujen isoflavonit ja niiden pitoisuudet plasmassa

  2008cites this paper
• The effect of dietary protein intake on coronary heart disease risk

  2008cites this paper
• Soy and cardio-metabolic abnormalities: an update

  2008cites this paper
• The Effects of Soy Isoflavones on Obesity

  2008cites this paper
• Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S. adults.

  2008cites this paper
• Probiotic capsules do not lower plasma lipids in young women and men

  2008cites this paper
• Effect of soy proteins and isoflavones on lipid metabolism and involved gene expression.

  2008cites this paper
• Lipids in Health and Disease

  2008cites this paper
• The evidence for dietary prevention and treatment of cardiovascular disease.

  2008cites this paper
• Complementary and alternative medicine and the management of the metabolic syndrome.

  2008cites this paper
• Lipids in Health and Disease

  2008cites this paper
• Beneficial Effects of Soybean Diet on Serum Marker Enzymes, Lipid Profile and Relative Organ Weights of Wistar Rats

  2008cites this paper
• Human Nutrition Value of Soybean Oil and Soy Protein

  2008cites this paper
• Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol.

  2008cites this paper
• Soy protein without isoflavones reduces aortic total and cholesterol ester concentrations greater than soy protein with isoflavones compared with casein in hypercholesterolemic hamsters

  2007cites this paper
• Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women.

  2007cites this paper
• Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials.

  2007influential citation
• Soy Isoflavones as Safe Functional Ingredients

  2007cites this paper
• Soy protein, soybean isoflavones and coronary heart disease risk: where do we stand?

  2007influential citation
• Cardiovascular disease risk factors in postmenopausal women : excess iron is related to central adiposity but not to oxidative stress

  2006cites this paper
• Evaluation of Physicochemical Properties of Muffins Made With Ultrafiltered Sunmul Powder

  2006cites this paper